Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-26 @ 4:12 AM
Study NCT ID:
NCT00064727
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2003-07-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07-09
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-04-11
Completion Date Type:
None
First Submit Date:
2003-07-10
First Submit QC Date:
None
Study First Post Date:
2003-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-30
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL